OrbusNeich Medical Group Holdings Limited (HKG:6929)
Hong Kong
· Delayed Price · Currency is HKD 3.850
+0.030 (0.79%)
Apr 29, 2026, 3:59 PM HKT
HKG:6929 Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 180.45 | 164.1 | 153.87 | 136.82 | 116.46 | Upgrade
|
| Revenue Growth (YoY) | 9.97% | 6.65% | 12.46% | 17.48% | 31.64% | Upgrade
|
| Cost of Revenue | 58.02 | 49.63 | 47.37 | 44.37 | 35.29 | Upgrade
|
| Gross Profit | 122.43 | 114.47 | 106.5 | 92.46 | 81.17 | Upgrade
|
| Selling, General & Admin | 67.38 | 62.7 | 54.84 | 55.13 | 50.06 | Upgrade
|
| Research & Development | 15.73 | 17.05 | 14.38 | 14.11 | 12.15 | Upgrade
|
| Other Operating Expenses | -0.69 | -0.44 | -2.14 | -0.92 | -1.4 | Upgrade
|
| Operating Expenses | 83.09 | 79.65 | 67.14 | 68.57 | 60.7 | Upgrade
|
| Operating Income | 39.34 | 34.82 | 39.36 | 23.89 | 20.48 | Upgrade
|
| Interest Expense | -0.17 | -0.22 | -0.13 | -1.46 | -5.61 | Upgrade
|
| Interest & Investment Income | 8.86 | 11.92 | 10.67 | 2.39 | 0.01 | Upgrade
|
| Earnings From Equity Investments | -1.32 | -1.51 | -0.84 | -0.2 | -0.21 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.78 | -0.71 | -0.36 | -0.97 | -0.9 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | -0 | -0.01 | -0.01 | -0 | Upgrade
|
| EBT Excluding Unusual Items | 47.47 | 44.3 | 48.69 | 23.65 | 13.77 | Upgrade
|
| Impairment of Goodwill | - | -1.57 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.24 | -0.28 | 0.98 | -1.49 | -0.05 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.1 | -0.01 | -0.05 | -0.03 | -0.08 | Upgrade
|
| Asset Writedown | - | - | - | -0.34 | - | Upgrade
|
| Other Unusual Items | -0.05 | -0.03 | 0.01 | 0 | -14.96 | Upgrade
|
| Pretax Income | 47.09 | 42.41 | 49.63 | 21.79 | -1.32 | Upgrade
|
| Income Tax Expense | 5.05 | 2.56 | 4.56 | 3.3 | 3.13 | Upgrade
|
| Earnings From Continuing Operations | 42.03 | 39.85 | 45.07 | 18.49 | -4.44 | Upgrade
|
| Minority Interest in Earnings | -0.13 | -0.13 | - | - | - | Upgrade
|
| Net Income | 41.9 | 39.72 | 45.07 | 18.49 | -4.44 | Upgrade
|
| Net Income to Common | 41.9 | 39.72 | 45.07 | 18.49 | -4.44 | Upgrade
|
| Net Income Growth | 5.49% | -11.88% | 143.76% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 824 | 826 | 828 | 583 | 577 | Upgrade
|
| Shares Outstanding (Diluted) | 826 | 826 | 833 | 776 | 577 | Upgrade
|
| Shares Change (YoY) | -0.09% | -0.80% | 7.29% | 34.58% | - | Upgrade
|
| EPS (Basic) | 0.05 | 0.05 | 0.05 | 0.03 | -0.01 | Upgrade
|
| EPS (Diluted) | 0.05 | 0.05 | 0.05 | 0.03 | -0.01 | Upgrade
|
| EPS Growth | 5.62% | -11.09% | 111.85% | - | - | Upgrade
|
| Free Cash Flow | 3.42 | 3.32 | 17.43 | 20.53 | 19.25 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | 0.00 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Dividend Per Share | 0.015 | 0.013 | 0.013 | - | - | Upgrade
|
| Dividend Growth | 20.31% | - | - | - | - | Upgrade
|
| Gross Margin | 67.85% | 69.76% | 69.22% | 67.57% | 69.70% | Upgrade
|
| Operating Margin | 21.80% | 21.22% | 25.58% | 17.46% | 17.58% | Upgrade
|
| Profit Margin | 23.22% | 24.20% | 29.29% | 13.51% | -3.82% | Upgrade
|
| Free Cash Flow Margin | 1.89% | 2.02% | 11.33% | 15.01% | 16.53% | Upgrade
|
| EBITDA | 42.78 | 37.59 | 41.3 | 25.84 | 22.86 | Upgrade
|
| EBITDA Margin | 23.71% | 22.91% | 26.84% | 18.89% | 19.63% | Upgrade
|
| D&A For EBITDA | 3.44 | 2.77 | 1.94 | 1.95 | 2.39 | Upgrade
|
| EBIT | 39.34 | 34.82 | 39.36 | 23.89 | 20.48 | Upgrade
|
| EBIT Margin | 21.80% | 21.22% | 25.58% | 17.46% | 17.58% | Upgrade
|
| Effective Tax Rate | 10.73% | 6.04% | 9.18% | 15.14% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.